SCHEMBL7680971

SCHEMBL7680971

OC(c1ccncc1)c1ccncc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.67
CYP19A1 P11511 2/20 0.67
CYP11B1 P15538 2/20 0.67
CYP11B2 P19099 2/20 0.67
CYP17A1 P05093 2/20 0.67
SMN1; SMN2 Q16637 2/20 0.50
SLC6A2 P23975 2/20 0.48
SLC6A4 P31645 2/20 0.48
SLC6A3 Q01959 2/20 0.48
CYP2C19 P33261 3/20 0.46
LTA4H P09960 1/20 0.44
KDM4E B2RXH2 1/20 0.43
HSD17B10 Q99714 1/20 0.43
CYP2D6 P10635 2/20 0.43
CYP1A2 P05177 2/20 0.43
CYP2C9 P11712 2/20 0.43
LMNA P02545 2/20 0.42
MAPT P10636 2/20 0.42
BRD4 O60885 1/20 0.41
HDAC8 Q9BY41 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL477399 0.89 SMN1; SMN2 (0.65) CYP3A4CYP19A1CYP11B1CYP11B2CYP17A1
SCHEMBL257973 0.85 CYP19A1 (0.59) CYP3A4CYP19A1CYP11B1CYP11B2CYP17A1
SCHEMBL11196968 0.85 CYP19A1 (0.59) CYP3A4CYP19A1CYP11B1CYP11B2CYP17A1
SCHEMBL8737044 0.85 CYP19A1 (0.59) CYP3A4CYP19A1CYP11B1CYP11B2CYP17A1
SCHEMBL2907043 0.85 CYP19A1 (0.68) CYP3A4CYP19A1CYP11B1CYP11B2CYP17A1
SCHEMBL23882924 0.85 CYP19A1 (0.59) CYP3A4CYP19A1CYP11B1CYP11B2CYP17A1
SCHEMBL5512809 0.85 CYP19A1 (0.59) CYP3A4CYP19A1CYP11B1CYP11B2CYP17A1
SCHEMBL3543535 0.82 CYP19A1 (0.55) CYP3A4CYP19A1CYP11B1CYP11B2CYP17A1
SCHEMBL18228789 0.82 SMN1; SMN2 (0.81) CYP3A4CYP19A1CYP11B1CYP11B2CYP17A1
SCHEMBL1892118 0.81 CYP3A4 (0.48) CYP3A4CYP19A1CYP11B1CYP11B2CYP17A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104926888-B A kind of cobalt complex and preparation method and application 南京信息工程大学 2017-09-19 CN claimed
US-6342503-B1 ANTIDEPRESSANTS, EATING DISORDERS DUPONT PHARMACEUTICALS COMPANY 2002-01-29 US disclosed
US-5405843-A Anticancer drug potentiators MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1995-04-11 US disclosed
EP-0363212-B1 Novel heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components MITSUI TOATSU CHEMICALS (JP) 1995-01-04 EP disclosed
US-5204348-A Quinoline derivatives MITSUI TOATSU CHEMICALS INC. (JP) 1993-04-20 US disclosed
US-5112817-A Anticancer Drug Potentiators MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1992-05-12 US disclosed
EP-0363212-A2 Novel heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components MITSUI TOATSU CHEMICALS, Inc. (JP) 1990-04-11 EP disclosed